Both SLCO4A1 and SLCO4C1 facilitate the excretion of various drugs and compounds, including methotrexate, thyroid hormones, and E-3-S, with elevated expression reported in BC cell lines [49,50,51,52,53]. This evidence concerns the gene SLCO4A1 and breast cancer.